Skip to main content

Advertisement

Log in

Simvastatin use associated with low intraocular ADP levels in patients with sight-threatening diabetic retinopathy

  • Letter to the Editor
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Eltzschig HK, Sitkovsky MV, Robson SC (2012) Purinergic signaling during inflammation. N Engl J Med 367:2322–2333. doi:10.1056/NEJMra1205750

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Sugiyama T (2014) Role of P2X7 receptors in the development of diabetic retinopathy. World J Diabetes 5:141–145. doi:10.4239/wjd.v5.i2.141

    PubMed  PubMed Central  Google Scholar 

  3. Costa G, Pereira T, Neto AM, Cristovao AJ, Ambrosio AF, Santos PF (2009) High glucose changes extracellular adenosine triphosphate levels in rat retinal cultures. J Neurosci Res 87:1375–1380. doi:10.1002/jnr.21956

    Article  CAS  PubMed  Google Scholar 

  4. Loukovaara S, Sahanne S, Jalkanen S, Yegutkin GG (2015) Increased intravitreal adenosine 5'-triphosphate, adenosine 5'-diphosphate and adenosine 5'-monophosphate levels in patients with proliferative diabetic retinopathy. Acta Ophthalmol 93:67–73. doi:10.1111/aos.12507

    Article  CAS  PubMed  Google Scholar 

  5. Bellosta S, Ferri N, Arnaboldi L, Bernini F, Paoletti R, Corsini A (2000) Pleiotropic effects of statins in atherosclerosis and diabetes. Diabetes Care Suppl 2:B72–B78

    Google Scholar 

  6. Tuuminen R, Sahanne S, Loukovaara S (2014) Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment. Acta Ophthalmol 92:675–681. doi:10.1111/aos.12363

    Article  CAS  PubMed  Google Scholar 

  7. Lee SG, Kim JL, Lee HK, Ryu GW, Hur DY, Yun IH, Yang JW, Kim HW (2011) Simvastatin suppresses expression of angiogenic factors in the retinas of rats with streptozotocin-induced diabetes. Graefes Arch Clin Exp Ophthalmol 249:389–397. doi:10.1007/s00417-010-1496-5

    Article  CAS  PubMed  Google Scholar 

  8. Jalkanen J, Yegutkin GG, Hollmen M, Aalto K, Kiviniemi T, Salomaa V, Jalkanen S, Hakovirta H (2015) Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis. Circ Res 116:1206–1215. doi:10.1161/CIRCRESAHA.116.305715

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Raimo Tuuminen.

Ethics declarations

Funding

This study was supported by grants from the Finnish Eye Foundation, the Eye and Tissue Bank Foundation, the Mary and Georg C. Ehrnrooth Foundation, the Nissi Foundation, the Waldemar von Frenckells Foundation, and HUCH Clinical research grants (TKK4150 and TYH1325). The sponsors had no role in the design or conduct of this research.

Conflict of Interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tuuminen, R., Yegutkin, G.G., Jalkanen, S. et al. Simvastatin use associated with low intraocular ADP levels in patients with sight-threatening diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 254, 1643–1644 (2016). https://doi.org/10.1007/s00417-016-3349-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-016-3349-3

Keywords

Navigation